10 Top Stories for a Newsworthy 2024
University of Manitoba10 top stories for a newsworthy 2024
10 top stories for a newsworthy 2024
Astatine-211 (At-211) is a promising alpha emitting radioisotope for cancer therapy, but its short 7.2-hour half-life means that it must be handled quickly to minimize losses due to radioactive decay. In this research, scientists designed and tested an automated device for producing At-211 that improves production time and efficiency. The device also minimizes the dose of radioactivity to production staff and reduces the time needed to prepare samples for shipment.
At the Department of Energy’s Office of Science, 2024 brought big accomplishments enabled by decades of work as well as advances that are establishing the foundations for future research. From Nobel Prizes to a new exascale computer, the DOE’s Office of Science is leading the way.
Top advocacy goals the American Society of Nephrology (ASN) has championed throughout the 118th Congress have been included in draft text for a large end-of-year legislative package on Capitol Hill.
NIH awarded more than $4 million in funds and support services to three diagnostic technology developers as part of the RADx Tech’s Advanced Platforms for HIV Viral Load Monitoring program.
Marie-Pascale Pomey receives $200,000 in funding to create a platform to help people with rare cancers find reliable information and navigate the healthcare system.
“We will use optical genome mapping for molecular diagnosis of brain tumors, which is a new application of this technology specifically designed to detect structural variants, meaning large chan...
The microbiome is a vast community that changes how we digest food, how we respond to disease threats, and even how we think. But scientists are just scratching the surface of how our microscopic roommates affect our health.
Enver Cagri Izgu, PhD, from the School of Arts and Sciences at Rutgers-New Brunswick, and his team will use a nearly $2 million NIH grant to develop diverse molecules with “programmed functionality” to address the fundamental challenges in therapeutic approaches that rely on modulating gene expression.
Ochsner Health Network, LLC (OHN), the region’s largest physician-led clinically integrated network, is pleased to report its 2023 – 2024 impact resulting from care delivered to over a half million patients living throughout the Gulf South.
Cedars-Sinai is participating in a major national research and surgical effort aimed at curing total blindness through whole eye transplantation, a pioneering approach to restoring vision.
Sabahat Bokhari, a Rutgers professor of medicine and an amyloidosis expert, will direct a fellowship at Robert Wood Johnson University Hospital
The National Institutes of Health have awarded a team of researchers at WashU Medicine a grant to investigate the underlying causes of cerebral small vessel disease, which is the second-leading cause of dementia.
Jefferson Lab announces its newest slate of projects to receive Laboratory Directed Research & Development (LDRD) program funding for 2025. In its 12th year, the LDRD program will split $3 million among 13 different projects.
The National Eye Institute (NEI)—which is the most important source of funding for all of vision research in the U.S.—is being threatened by a proposal from a committee in the House of Representatives to collapse the National Institutes of Health’s (NIH) 27 institutes into 15 institutes.
Washington University School of Medicine in St. Louis has received a renewal of a prestigious research grant from the National Cancer Institute. Led by principal investigator, Daniel Link, MD, the Specialized Program of Research Excellence (SPORE) grant in leukemia provides funding for translational research.
Program Manager Alejandra Cortez, LCSW, recognizes that working with high school students is as much about learning as it is about teaching. “When we are working with youth, I see amazing growth both in the students and in my own team,” Cortez explains.Youth Advocate Dayanara Fonseca agrees. “We have worked with one student since her freshman year,” Fonseca says.
The federally funded pathway programs strive to increase diversity and equity in the cancer research field, a key strategy to reduce health disparities in the Chicagoland area and across the country.
Cedars-Sinai today announced a $35 million gift from Martha and Bruce Karsh and the Karsh Family Foundation. The major donation includes $30 million to establish the Karsh Division of Interventional Cardiology and $5 million to create the Karsh Distinguished Chair in Interventional Cardiology.